ProZyme, Inc. (extinct)

ProZyme, Inc. (extinct)

ProZyme, Inc. (extinct)

Overview
Date Founded

1990

Headquarters

3832 Bay Center Place,Hayward, CA 94545

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Chemicals
Industrial Machinery & Manufacturing
IT Consulting & Services
Medical Support Services
Biotechnology

Company Description

ProZyme, Inc. operates as a biotechnology company. The firm's services include high throughput N-Glycan screening, N-Glycan identification and characterization, N-Glycan analysis, N-Glycan remodeling & glycovariant production and custom phycobiliprotein conjugation. Its products include Gly-Q System, Gly-X Sample Prep, GlykoPrep, Glyko Enzymes, Glyko Standards, Glyko Tools, PhycoLink Conjugates & Activated Phycobiliproteins, PhycoPro Phycobiliproteins, Streptavidins and Purification Proteins. The company was founded in 1990 and is headquartered in Hayward, CA.

Website

http://prozyme.com

Contact Data
Trying to get in touch with decision makers at ProZyme, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
November 20, 2020
Global Glycobiology Market (2020 to 2025) - by Type of Enzyme, Type of Kit, Application, End-user and Region
GlobeNewswire
November 11, 2020
Worldwide Glycobiology Industry to 2025 - Impact Analysis of COVID-19
Business Wire
December 2, 2019
Global Glycomics/Glycobiology Market Size, Share & Trends Analysis Report 2019-2026: Focus on Applications (Drug Discovery & Development, Diagnostics), Products (Instruments, Enzymes) - ResearchAndMarkets.com
PR Newswire
November 9, 2018
Global Glycomics/Glycobiology (Instruments, Enzymes, Kits, Reagents) Market Analysis 2017-2025 - High investments Driving the Development of New Glycobiology Tools
PR Newswire
October 16, 2018
Glycomics/Glycobiology Market Size Worth $2.1 Billion by 2025: Grand View Research, Inc.

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Trending People
Netflix, Inc.
Telling the tale of murder; The death of a Swedish journalist in Copenhagen shoc... - The Independent UK
Alibaba Group Holding Ltd.
Alibaba's Jack Ma makes first public appearance since Oct in online meeting -sta... - Nasdaq
United States Department of Treasury
PRECIOUS-Gold gains as U.S. stimulus prospects weigh on dollar - Nasdaq
New York Stock Exchange LLC
Continental Resources to Announce Full-Year 2020 and Fourth Quarter 2020 Results... - Nasdaq
United States Senate
Trump is considering starting the 'Patriot Party' after facing criticism from to... - Business Insider
Trending Organizations
Netflix, Inc.
Telling the tale of murder; The death of a Swedish journalist in Copenhagen shoc... - The Independent UK
Alibaba Group Holding Ltd.
Alibaba's Jack Ma makes first public appearance since Oct in online meeting -sta... - Nasdaq
United States Department of Treasury
PRECIOUS-Gold gains as U.S. stimulus prospects weigh on dollar - Nasdaq
New York Stock Exchange LLC
Continental Resources to Announce Full-Year 2020 and Fourth Quarter 2020 Results... - Nasdaq
United States Senate
Trump is considering starting the 'Patriot Party' after facing criticism from to... - Business Insider
Paths to ProZyme, Inc.
Potential Connections via
Relationship Science
You
ProZyme, Inc.
Recent Transactions
Details Hidden

Agilent Technologies, Inc. purchases ProZyme, Inc.

Details Hidden

ProZyme, Inc. raised money in a private placement transaction

Transaction Advisors
Legal Advisor
Pillsbury Winthrop Shaw Pittman LLP

Advised onAgilent Technologies, Inc. purchases ProZyme, Inc.

Legal Advisor
Andrew Gajkowski

Advised onAgilent Technologies, Inc. purchases ProZyme, Inc.

Legal Advisor
Jessica Lutrin

Advised onAgilent Technologies, Inc. purchases ProZyme, Inc.

Legal Advisor
Jonathan J. Russo

Advised onAgilent Technologies, Inc. purchases ProZyme, Inc.

Non-Profit Donations & Grants
$1,000 +
2012
Northeastern University

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ProZyme, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ProZyme, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ProZyme, Inc..